Press "Enter" to skip to content

New patent for Bpi Labs drug EPINEPHRINE

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for EPINEPHRINE
Annual Drug Patent Expirations for EPINEPHRINE

Epinephrine is a drug marketed by Armstrong Pharms, Am Regent, Bpi Labs, Intl Medication Sys, Hospira, and Teva Pharms Usa and, and is included in seven NDAs. It is available from ten suppliers. There are three patents protecting this drug.

EPINEPHRINE drug price trends.

Drug patent litigation for EPINEPHRINE.

The generic ingredient in EPINEPHRINE is epinephrine. Ten suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the epinephrine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions